Hottest Stocks
(Over $10)
Hottest Stocks
($2-$10)
Biggest Losers
(Over $10)
Biggest Losers
($2-$10)
Hottest
Industries
Hottest
Sectors
EPS / Sales
Surprises
 
Enter Ticker Symbol:   Ticker Lookup
 

Enter any portion of the company’s name to find its corresponding ticker symbol:
Search for :   

Zacks Company Profile for SRX Health Solutions, Inc. (SRXH : AMEX)
 
 • Company Description   
SRx Health Solutions Inc. operates as a healthcare service provider specializing in the Specialty Pharmacy segment of the pharmaceutical industry. SRx Health Solutions Inc., formerly known as Better Choice Company Inc., is based in TAMPA, Fla.

Number of Employees: 21

 
 • Price / Volume Information   
Yesterday's Closing Price: $0.27 Daily Weekly Monthly
20 Day Moving Average: 1,456,176 shares
Shares Outstanding: 24.85 (millions)
Market Capitalization: $6.66 (millions)
Beta: 1.00
52 Week High: $2.02
52 Week Low: $0.22
Short Interest Ratio:
  % Price Change % Price Change Relative to S&P 500
4 Week -26.56% -26.40%
12 Week -1.07% -4.78%
Year To Date -84.61% -86.53%
 
 • Address & Contact Information
Street Address Phone / Fax Email Address Web URL
12400 Race Track Road
-
Tampa,FL 33626
USA
ph: 212-896-1254
fax: -
valter@kcsa.com https://srxhealth.ca
 
 • General Corporate Information   
Officers
Kent Cunningham - Chief Executive Officer
Michael Young - Chairman of the Board of Directors
Carolina Martinez - Chief Financial Officer; Secretary and Treasurer
Lionel F. Conacher - Director
Gil Fronzaglia - Director

Peer Information
SRX Health Solutions, Inc. (CHCR)
SRX Health Solutions, Inc. (ESRX)
SRX Health Solutions, Inc. (MYDP)
SRX Health Solutions, Inc. (COR)
SRX Health Solutions, Inc. (GBCS)
SRX Health Solutions, Inc. (LAXAF)
Industry / Sector / Ticker Info
Analyst Coverage: No
Industry Group: Medical Services
Sector: Medical
CUSIP: 08771Y402
SIC: 2080
Fiscal Year
Fiscal Year End: September
Last Reported Quarter: 06/01/25
Next Expected EPS Date: 11/11/25
Share - Related Items
Shares Outstanding: 24.85
Most Recent Split Date: 4.00 (1.35:1)
Beta: 1.00
Market Capitalization: $6.66 (millions)
 
 
 • EPS Information     • Dividend Information
Analyst Coverage: No Dividend Yield: 0.00%
Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00
Current Fiscal Year EPS Consensus Estimate: $ Payout Ratio:
Number of Estimates in the Fiscal Year Consensus: Change In Payout Ratio:
Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00
Next EPS Report Date: 11/11/25  
 

 • Fundamental Ratios
P/E
Current FY Estimate: -
Trailing 12 Months: -
PEG Ratio: -
Price Ratios
Price/Book: -
Price/Cash Flow: 0.40
Price / Sales: 0.18
EPS Growth
vs. Year Ago Period: 2.06%
vs. Previous Quarter: -100.00%
Sales Growth
vs. Year Ago Period: 34.01%
vs. Previous Quarter: 59.90%
ROE
09/30/25 - -
06/30/25 - -
03/31/25 - -
ROA
09/30/25 - -
06/30/25 - -75.82
03/31/25 - -23.14
Current Ratio
09/30/25 - -
06/30/25 - 0.33
03/31/25 - 1.99
Quick Ratio
09/30/25 - -
06/30/25 - 0.26
03/31/25 - 1.37
Operating Margin
09/30/25 - -
06/30/25 - -50.45
03/31/25 - -13.17
Net Margin
09/30/25 - -
06/30/25 - -43.33
03/31/25 - 4.96
Pre-Tax Margin
09/30/25 - -
06/30/25 - -34.05
03/31/25 - 4.99
Book Value
09/30/25 - -
06/30/25 - -3.03
03/31/25 - 2.34
Inventory Turnover
09/30/25 - -
06/30/25 - -0.89
03/31/25 - 5.51
Debt-to-Equity
09/30/25 - -
06/30/25 - -
03/31/25 - 0.00
Debt-to-Capital
09/30/25 - -
06/30/25 - -
03/31/25 - 0.00
 

Powered by Zacks Investment Research ©